Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers
NCT03127046 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-04-25
Summary
To evaluate the drug-drug interaction between aceclofena and esomeprazole
Conditions
- Healthy
Interventions
- DRUG
-
Aceclofenac
Oral single dose administration of aceclofenac 200mg
- DRUG
-
Esomeprazole
Oral single dose administration of aceclofenac 200mg
- DRUG
-
Aceclofenac and Esomeprazole
Oral single dose administration of aceclofenac 200mg and esomeprazole concomitant
Sponsors & Collaborators
-
Dong Wha Pharmaceutical Co. Ltd.
lead INDUSTRY
Principal Investigators
-
Min-Gul Kim, PhD · Chonbuk National University Hospital in Korea
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-03-31
- Primary Completion
- 2017-04-16
- Completion
- 2017-04-23
- FDA Drug
- Yes
Countries
- South Korea
Study Locations
More Related Trials
-
Drug Interaction Study Between AZD3355 and Nexium
NCT00684190 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately
NCT01015729 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy of Esomeprazole in Patients With Frequent Heartburn
NCT01370525 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects
NCT01494402 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.
NCT00206245 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)
NCT00441727 ·Status: COMPLETED ·Phase: PHASE3
-
Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients
NCT00222131 ·Status: COMPLETED ·Phase: PHASE2
-
Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv
NCT00626262 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel
NCT01147588 ·Status: COMPLETED ·Phase: PHASE1
-
Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage
NCT00524329 ·Status: COMPLETED
-
Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions
NCT00612027 ·Status: COMPLETED
-
A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)
NCT00626535 ·Status: COMPLETED ·Phase: PHASE3
-
Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
NCT00241514 ·Status: COMPLETED ·Phase: PHASE3
-
Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
NCT00241553 ·Status: COMPLETED ·Phase: PHASE3
-
Reflux Esophagitis Phase III Study (Maintenance Treatment)
NCT00634114 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Drug Interaction Study Of Crizotinib With Esomeprazole.
NCT01549574 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Interaction Between Aspirin and Nexium
NCT01199328 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination
NCT00688428 ·Status: COMPLETED ·Phase: PHASE1
-
An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
NCT00629564 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects
NCT01159145 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole
NCT03980756 ·Status: COMPLETED ·Phase: PHASE1
-
Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
NCT00241527 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131
NCT04690868 ·Status: COMPLETED ·Phase: PHASE1
-
Acid-Associated Heartburn Symptoms and Dose of Esomeprazole
NCT00206024 ·Status: COMPLETED ·Phase: PHASE4
-
Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously
NCT00635414 ·Status: COMPLETED ·Phase: PHASE4